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Introduction {#sec1}
============

Induced pluripotent stem cell (iPSC) technology is rapidly revolutionizing diverse fields in biomedical sciences ([@bib13], [@bib36], [@bib37]). Notably, patient-derived iPSCs provide an invaluable source for deriving the affected cells in a specific patient, which can serve as an optimal model for the patient\'s disease. Accordingly, disease modeling using patient-derived iPSC has been overcoming various limitations inherent to other models, and this has been markedly accelerating both the mechanistic understanding of pathogenesis and the chemical screening for potential therapeutics. As well as being employed in basic investigations, cells differentiated from patient-derived iPSCs can also be used to predict drug response and side effects for stratifying patients in the clinic. Furthermore, patient-derived iPSCs have an unsurpassed impact on cell transplantation because they can serve as a source for deriving autografts that should have minimal risk of rejection and other adverse immune responses. The recent advent of genome-editing technologies has even enabled the correction of genetic insults *ex vivo* before autologous transplantation, which has further enhanced the power of regenerative medicine.

The first-in-human trial of iPSC-derived autologous transplantation was performed on a female patient with exudative age-related macular degeneration (AMD) ([@bib26]). AMD is a leading cause of visual impairment in elderly people and involves progressive degeneration of the retinal pigment epithelium (RPE), which plays a critical role in photoreceptor maintenance. The RPE represents an optimal tissue for replacement therapy performed using an iPSC-derived autologous graft because RPE cells are exceptionally safe, terminally differentiated cells that have not been found to undergo malignant transformation in any study reported thus far. Furthermore, a robust protocol has been established to prepare human iPSC-derived RPE sheets that meet clinical-use requirements in terms of quality, quantity, consistency, and safety ([@bib16]). In the first trial, iPSCs were generated from the patient\'s skin fibroblasts and used to derive the RPE, and a sheet of the iPSC-derived RPE (iRPE) was transplanted into a subretinal region of the patient\'s eye. The sheet survived well without showing any signs of rejection or unexpected proliferation at 1 year after surgery, thus successfully retaining the initial goal of the trial as reported previously ([@bib26]). At the time of preparation of this manuscript, the sheet has been properly functioning for 4 years, without causing any clinical problems in the patient (unpublished data).

Before transplantation, the iRPE sheet was subjected to a series of rigorous examinations, which included tests for tumorigenicity, genome integrity, and various functionalities. DNA methylation was also examined because the reprogramming of methylation is frequently incomplete, and the aberrant status can be transmitted to iPSC-derived cells ([@bib11], [@bib18]). These aberrations, which include hypermethylation of CpG islands (CGIs), loss of genomic imprinting, and incomplete inactivation of female X chromosome, could be transmitted to the iRPE and thus pose a potential risk of abnormal proliferation and compromised functions. Therefore, a targeted methylome analysis, using the well-established Infinium 450K methylation array, was conducted to confirm that the iRPE methylome was not only closer to that of the RPE than those of other tissues, but also free from apparent risks such as the CGI methylation of tumor-suppressor genes ([@bib26]).

To elucidate the iRPE methylome more comprehensively than before, we conducted whole-genome bisulfite sequencing (WGBS) of (1) fibroblasts from the female patient who received the iRPE transplantation (patient 1); (2) the iPSCs induced from the fibroblasts; (3) the iRPE sheet derived from the iPSCs; and (4) the iRPE xenotransplanted to the hypodermis of non-obese diabetic/SCID mice (xRPE) ([@bib26]). Moreover, we analyzed the same set of samples derived from a male patient (patient 2), transplantation to whom was not performed because of genetic insults identified in the genome of the patient\'s iRPE sheet and the relatively stable clinical symptoms of the patient ([@bib26]). We also examined four distinct batches of RPE cultured *in vitro* (cRPE) and native RPE obtained from four autopsy specimens (nRPE) ([@bib26]). A series of comparative analyses of these WGBS data revealed an overall resemblance and several differences between the iRPE and nRPE methylomes. Although a previous analysis performed using reduced representation bisulfite sequencing (RRBS) has been reported on human embryonic stem cell (ESC)-derived RPE, iPSC-derived RPE, and fetal RPE cell lines ([@bib23]), our WGBS study is considerably more comprehensive and uncovers heretofore undescribed methylomic features of iRPE and nRPE.

Results {#sec2}
=======

Emergence of Partially Methylated Domains in iRPE {#sec2.1}
-------------------------------------------------

We used the post-bisulfite adaptor tagging (PBAT) method ([@bib27], [@bib28]) to generate PCR-free WGBS data from the fibroblasts, iPSCs, iRPE, and xRPE derived from the two AMD patients reported previously ([@bib26]). Moreover, we similarly analyzed four each of the cRPE and nRPE samples as the controls for iRPE ([Table S1](#mmc2){ref-type="supplementary-material"}).

The overall CpG methylation (mCG) levels were largely comparable among the 16 samples examined, except in the case of fibroblasts ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). The low mCG levels detected in the fibroblasts were expected because these cells are known to harbor partially methylated domains (PMDs). PMDs were first detected in the human fibroblast cell line IMR90 as genomic regions that were larger than 10 kb in size and below 70% in mean mCG level, often overlapping with lamina-associated domains (LADs) ([@bib20]). PMDs are also prominent in the placenta and in various cancer cells ([@bib24]).Figure 1Emergence of PMDs in iRPE(A) Mean mCG levels of the 16 methylomes determined in this study.(B) MDL plots for methylome segmentation. For each domain defined by a change-point detection approach, mean methylation level in percentile (y axis) is plotted against log10 of its size in base pairs (x axis) ([@bib39]). Yellow lines demarcate domains that fulfill the original criteria of PMDs (size \>10 kb; mean methylation level \<70%) ([@bib20]).(C) Venn diagram for overlap among PMDs in fibroblasts, iRPE, and cRPE. Note that pan-cRPE represents the union of PMDs in cRPE1--4. The number indicates the total size (Mb) of genomic regions in each section of the Venn diagram.

To screen for the presence of PMDs and other large methylomic alterations, we used a change-point detection algorithm to segment each methylome into distinct domains according to their mean mCG levels ([@bib39]). To visualize global trends in methylome segmentation, we displayed the domain composition of each methylome using a plot termed Methylated Domain Landscape (MDL), in which the mean mCG level of each domain was plotted against its size ([@bib39]) ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}B). MDL plots confirmed that the patient-derived fibroblasts harbored prominent PMDs ([Figure 1](#fig1){ref-type="fig"}B). In agreement with the study on IMR90 cells ([@bib20]), PMDs occupied up to approximately one-third of the patient-derived fibroblast genome (1,151 and 1,033 Mb in patients 1 and 2, respectively) ([Figure 1](#fig1){ref-type="fig"}C), and most of these PMDs (93% and 96% in patients 1 and 2) disappeared upon reprogramming, as also reported previously ([@bib21]) ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}C).

Notably, PMDs emerged during the differentiation from iPSCs to iRPE ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}C). Compared with PMDs in fibroblasts, PMDs appeared in iRPE occupied considerably smaller regions in the genome ([Figures 1](#fig1){ref-type="fig"}B and 1C) and were less demethylated (Wilcoxon test, p \< 2.2 × 10^−16^ in both patients 1 and 2) ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Importantly, most PMDs in iRPE (90% and 87% in patients 1 and 2, respectively) overlapped with PMDs in the fibroblasts, suggestive of their physiological nature ([Figure 1](#fig1){ref-type="fig"}C). The PMDs shared between fibroblasts and iRPE were less methylated in the fibroblasts than in the iRPE ([Figure S1](#mmc1){ref-type="supplementary-material"}D), and their methylation levels were below the overall average in fibroblasts ([Figure S1](#mmc1){ref-type="supplementary-material"}D). These common PMDs either recurred during differentiation (recurrent PMDs, 65% and 79% in patients 1 and 2, respectively) or inherited from iPSC (persistent PMDs, 35% and 21% in patients 1 and 2, respectively) ([Figure S1](#mmc1){ref-type="supplementary-material"}C). As might be expected, methylation levels were generally lower in the persistent PMDs than in the recurrent PMDs ([Figure S1](#mmc1){ref-type="supplementary-material"}E).

Intriguingly, in contrast to fibroblasts and iRPE, the nRPE harbored only a negligible level of PMDs ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}B). Thus, iRPE failed to recapitulate the PMD paucity observed in nRPE. However, cRPE also displayed signs of PMD emergence, presumably as a physiological response to *in vitro* cultivation ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}B). To approximate the physiological PMDs induced in normal RPE by *in vitro* cultivation, we assessed the combined PMDs in the four cRPE samples (pan-cRPE PMDs). Based on considering the pan-cRPE PMDs, we estimated that the iRPE-specific PMDs accounted for \<5.2% and \<7.2% of the PMDs in iRPE1 and iRPE2, respectively ([Figure 1](#fig1){ref-type="fig"}C). Therefore, induction of most if not all PMDs in iRPE was likely a physiological response to *in vitro* cultivation. Nevertheless, once induced, the PMDs appeared to be stable: they persisted even 1 year after xenotransplantation to mouse (i.e., they were retained in xRPE) ([Figure 1](#fig1){ref-type="fig"}B).

Methylomic Evidence for Proper Differentiation and Memory of Reprogramming in iRPE {#sec2.2}
----------------------------------------------------------------------------------

To evaluate the overall resemblance among the 16 methylomes, we employed three hierarchical clustering methods, in each of which we used the raw mCG levels, the outputs of principal-component analysis (PCA), or those of independent component analysis (ICA).

We initially performed the clustering using the mean mCG levels of 100-kb sliding windows that covered entire autosomes. Both raw mCG level-based and ICA-based clustering revealed not only the expected proximity between iRPE and cRPE, but also an apparently counterintuitive proximity between iPSCs and nRPE ([Figure S2](#mmc1){ref-type="supplementary-material"}A). We suspected that PMDs were potentially responsible for this proximity between iPSCs and nRPE, because both iPSCs and nRPE lacked PMDs ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}B). Indeed, the proximity was resolved when the genomic regions corresponding to PMDs in fibroblasts (i.e., the PMD-prone regions) were masked in clustering ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Conversely, the proximity was recapitulated in the clustering using the PMD-prone regions ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Thus, we concluded that the counterintuitive proximity between iPSCs and nRPE can be attributed to their lack of PMDs. To minimize the effects of PMDs, we used the methylation levels of distinct genomic features in the following clustering analysis.

We first conducted clustering using the mean mCG levels of promoters or genomic regions within 2 kb upstream of transcription start sites (TSSs). Whereas the ICA-based clustering accurately classified the 16 samples into the expected 6 cell types, the other two approaches regarded one of the nRPE samples (nRPE1) as a cRPE ([Figures 2](#fig2){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}B). Nevertheless, all types of RPEs (iRPE, xRPE, cRPE, and nRPE) formed a monophyletic clade that excluded the non-RPE cells (iPSCs and fibroblasts), regardless of the clustering method used. The nearest neighbor of iRPE/xRPE was identified as cRPE in ICA-based clustering, whereas it was identified as cRPE/nRPE in the two other approaches ([Figures 2](#fig2){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}B). Thus, promoter methylation appeared to accurately reflect the status of cellular differentiation. In this context, independent component (IC) 12 was particularly intriguing because it clearly distinguished all types of RPE from the non-RPE cells ([Figure 2](#fig2){ref-type="fig"}B). The promoters making large contributions to IC12 were significantly enriched for those of RPE signature genes ([@bib4], [@bib19], [@bib35]) (Fisher\'s exact test, p = 6.1 × 10^−6^; odds ratio = 7.8) ([Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}C).Figure 2Genomic Feature-Dependent Differential Clustering of iRPE Methylome(A) ICA-based clustering using the methylation levels of promoters. The color scale indicates element values of the mixing matrix A of ICA ([@bib12]). The columns of A are used for clustering of samples. Note that the nearest neighbor of iRPE/xRPE is cRPE. The arrow indicates the row of A corresponding to IC12.(B) Differential weighting of IC12 between RPE and non-RPE cells. Element values in the row of A corresponding to IC12 are plotted for individual samples (^∗^p \< 0.01 by Wilcoxon test).(C) Methylation heatmap of promoters with significant contributions to IC12 (absolute value of loadings ≥5). Promoters of RPE signature genes are indicated on the right of the heatmap (RPE sig).(D) ICA-based clustering using the methylation levels of CGIs. The color scale indicates element values in the mixing matrix A of ICA ([@bib12]). The columns of A are used for clustering of samples. Note that the nearest-neighbor of iRPE/xRPE is iPSC. The arrow indicates the row of A corresponding to IC14.(E) Differential weighting of IC14 between reprogrammed and non-reprogrammed cells. Element values in the row of A corresponding to IC14 are plotted for individual samples (^∗∗^p \< 0.001 by Wilcoxon test).(F) Methylation heatmap of CGIs with significant contributions to IC14 (absolute value of loadings ≥5). CGIs proximal to genes involved in "homophilic cell adhesion via plasma membrane adhesion molecules" are indicated on the right of heatmap (GO: 0007156).

Next, we performed clustering using the mean mCG levels of CGIs. Here, the 16 samples were accurately classified into the expected six cell types with all three approaches ([Figures 2](#fig2){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}D). Notably, clustering using CGIs divided the samples into two clusters, one composed of natural or non-reprogrammed cells (fibroblasts, cRPE, and nRPE), and the other comprising cells that had experienced reprogramming (iPSCs, iRPE, and xRPE), regardless of the clustering approach used ([Figures 2](#fig2){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}D). Here IC14 was noteworthy because it clearly discriminated between the non-reprogrammed and reprogrammed cells ([Figure 2](#fig2){ref-type="fig"}E). Major contributors to IC14 were enriched for CGIs proximal to genes involved in homophilic cell adhesion (p \< 1.0 × 10^−30^) ([Figure 2](#fig2){ref-type="fig"}F and [Table S2](#mmc2){ref-type="supplementary-material"}).

Finally, we used the mean mCG levels of gene bodies (i.e., the mCG levels of exons and introns) for the clustering analysis. The ICA-based clustering accurately classified the 16 samples into the 6 cell types ([Figure S2](#mmc1){ref-type="supplementary-material"}E), whereas the other two approaches again misclassified nRPE1 as a cRPE sample ([Figure S2](#mmc1){ref-type="supplementary-material"}F). Notably, clustering using gene bodies not only failed to exclude iPSCs from the monophyletic clade including all RPEs, but also identified iPSCs as the nearest neighbor of iRPE/xRPE ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F). Since clustering using CGIs also identified iPSC as the nearest neighbor of iRPE/xRPE ([Figure 2](#fig2){ref-type="fig"}D), we sought to ascertain whether the CGIs in gene bodies might contribute to the apparent proximity of iPSCs and iRPE/xRPE. Accordingly, we focused on IC5, which discriminated between the reprogrammed and non-reprogrammed cells ([Figure S2](#mmc1){ref-type="supplementary-material"}E). The major contributors to IC5 notably exhibited high CGI density ([Figure S2](#mmc1){ref-type="supplementary-material"}G). Conversely, when CGIs were masked, the proximity between iPSCs and iRPE/xRPE was resolved ([Figure S2](#mmc1){ref-type="supplementary-material"}H). Therefore, CGIs appeared to be responsible for the proximity of iPSCs and iRPE/xRPE in clustering using gene bodies. We were also intrigued by IC4, which largely distinguished between the cells cultivated *in vitro* (fibroblasts, iPSCs, iRPE, and cRPE) and those derived from *in vivo* (xRPE and nRPE) ([Figure S2](#mmc1){ref-type="supplementary-material"}E). However, major contributors to IC4 failed to exhibit enrichment of any specific function (data not shown). In the same context, it is notable that raw mCG level-based clustering using RPE signature gene bodies clearly distinguished between the cells derived from the *in vitro* and *in vivo* settings ([Figure S2](#mmc1){ref-type="supplementary-material"}I). Thus, we assumed that gene-body methylation was partly sensitive to the cellular environment.

Collectively, the clustering results indicated that methylation patterns of individual genomic features reflect distinct aspects of cellular states, including differentiation, experience of reprogramming, and environment. The iRPE methylome supported proper differentiation from iPSCs to RPE, but concurrently exhibited deviation from the nRPE methylome, including the remnant of iPSC-like methylation patterns.

Origin and Fate of Genomic Regions Differentially Methylated between iRPE and nRPE {#sec2.3}
----------------------------------------------------------------------------------

Following the analysis of global methylation patterns, we focused on differentially methylated regions (DMRs) between iRPE and nRPE, and identified the DMRs using the software metilene ([@bib14]). To eliminate the effects of sex difference, we excluded both chromosomes X and Y from the analysis. Consequently, we identified 3,020 and 1,906 genomic regions that were hypermethylated and hypomethylated in iRPE relative to nRPE, respectively, which we hereafter refer to as hyper-DMRs and hypo-DMRs ([Tables S3](#mmc2){ref-type="supplementary-material"} and [S4](#mmc2){ref-type="supplementary-material"}). The hyper-DMRs and hypo-DMRs comprised 2.81 and 3.51 Mb, or 0.10% and 0.12%, of the autosomal genome, respectively, which means that ∼99.8% of the autosomal methylome was indistinguishable between iRPE and nRPE under the criteria used (q value \< 0.01; methylation difference \>30%; number of CpGs ≥20). These results reinforced the close resemblance between the two methylomes.

We next sought to examine the etiology of the DMRs by tracing their methylation status back in iPSCs. If the cognate region of a DMR was similarly methylated in iPSCs and ESCs, we concluded that the region was properly reprogrammed in iPSCs and that an error in its (de)methylation during differentiation resulted in the DMR. Conversely, if the cognate region of a DMR was differentially methylated between iPSCs and ESCs, and if the methylation status in iPSCs was transmitted to iRPE, we concluded that the DMR could be attributed to aberrant methylation upon reprogramming followed by a failure in its correction during differentiation. Moreover, we traced the fates of DMRs after xenotransplantation to predict their behaviors after autologous transplantation.

We used k-means clustering to classify the 3,020 hyper-DMRs into 5 clusters (clusters 1--5) and then performed hierarchical clustering on each of them to generate a methylation heatmap ([Figure 3](#fig3){ref-type="fig"}A). Although most if not all hyper-DMRs were similarly hypermethylated in iPSCs and ESCs, they were demethylated in nRPE but not iRPE. These results indicated that most hyper-DMRs had originated from demethylation errors during differentiation from iPSCs to iRPE rather than errors at reprogramming from fibroblasts to iPSCs. In terms of the fates of the hyper-DMRs, clusters 4 and 5 were particularly interesting because they were demethylated upon xenotransplantation, thus approaching the status of nRPE ([Figure 3](#fig3){ref-type="fig"}A). Intriguingly, these regions were largely depleted of CGIs, and this was in sharp contrast with clusters 1--3, whose hypermethylation was retained in xRPE ([Figure 3](#fig3){ref-type="fig"}A). Genes proximal to clusters 4 and 5 were notably enriched for RPE signature genes, genes involved in visual perception, and genes downregulated in iRPE relative to nRPE ([Figures 3](#fig3){ref-type="fig"}A and 3C). Accordingly, the genes exhibited enrichment for the binding motif of Otx2, a master regulator critically involved in RPE function ([@bib10]) ([Figure 3](#fig3){ref-type="fig"}D). By contrast, genes proximal to clusters 1--3 were enriched for those encoding proteins involved in homophilic cell adhesion, such as protocadherin gene clusters ([Figure 3](#fig3){ref-type="fig"}C). An RRBS study also reported hypermethylation of these genes in ESC- and iPSC-derived RPE relative to fetal RPE cell lines ([@bib23]).Figure 3Tracing the Origin and Fate of DMRs between iRPE and nRPE(A) Clustering of hyper-DMRs. The 3,020 hyper-DMRs are classified into five clusters (clusters 1--5). Methylation level and heatmap are shown for each cluster in the upper and lower panels, respectively. CGI and LAD indicate DMRs overlapped with CGIs and LADs, respectively. RPE sig and dw-DEG indicate hyper-DMRs within 5 kb from RPE signature genes and genes downregulated in iRPE relative to nRPE, respectively. The panels also include data on human ESC lines H1 and H9 ([@bib20]).(B) Clustering of hypo-DMRs. The 1,906 hypo-DMRs are classified into two clusters (clusters 6 and 7) and displayed similarly to (A).(C) GO enrichment analysis of DMR clusters.(D) Transcription factor-binding motif enrichment analysis of DMR clusters.

We similarly examined the 1,906 hypo-DMRs ([Figure 3](#fig3){ref-type="fig"}B). Hypo-DMRs were divided into 2 clusters (clusters 6 and 7). The larger cluster (cluster 6) comprised 74% of the hypo-DMRs and showed comparable hypermethylation in iPSCs and ESCs. Because these regions were retained in a hypermethylated state in nRPE but not iRPE, the hypo-DMRs in cluster 6 could likely be attributed to errors in maintenance methylation during differentiation. These hypo-DMRs were generally larger than hyper-DMRs, enriched for LADs to overlap with PMDs, and retained in a hypomethylated state after xenotransplantation ([Figure 3](#fig3){ref-type="fig"}B). Conversely, the smaller cluster (cluster 7) comprised 26% of the hypo-DMRs and was hypomethylated in both iPSCs and ESCs. Because these regions acquired intermediate levels of methylation in nRPE but not iRPE, the hypo-DMRs in cluster 7 could be attributed to errors in *de novo* methylation during differentiation. These hypo-DMRs were enriched for CGIs and proximal to genes involved in negative regulation of neural development ([Figure 3](#fig3){ref-type="fig"}C). Because these regions were also hypomethylated in cRPE, their hypomethylation in iRPE might have been induced by *in vitro* cultivation and could be mitigated *in vivo*. However, xenotransplantation failed to alter the hypomethylated status of these DMRs ([Figure 3](#fig3){ref-type="fig"}B).

Reprogramming-Induced Aberrant Methylation Persistent in iRPE {#sec2.4}
-------------------------------------------------------------

The results described above indicated that most DMRs could be attributed to (de)methylation errors during differentiation. However, some of the DMRs had clearly originated from aberrant methylation at reprogramming. For instance, eight of the nine reprogramming-associated epigenetic signature genes, which are frequently hypermethylated in iPSCs, but not ESCs ([@bib32]), were heavily methylated at their promoter regions in both iPSCs and iRPE in either or both of the two patients ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Moreover, seven out of these eight genes were among the top 1% contributors to IC5 of promoter clustering, which distinguished between the reprogrammed and non-reprogrammed cells ([Figures 2](#fig2){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}B). The genes were hypermethylated at their CGIs upon reprogramming, and the hypermethylation was maintained throughout differentiation and xenotransplantation, which led to their silencing, as exemplified by *DPP6* ([Figures 4](#fig4){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}C).Figure 4Persistence of Reprogramming-Induced Methylation Errors in iRPE(A) Genome browser shot of *DPP6*. From top to bottom, tracks represent CGIs, gene models, and mCG levels of both strands in Fibro1, 2; iPSC1, 2; iRPE1, 2; xRPE1, 2; nRPE1--4; and cRPE1--4. Note that promoter CGI is heavily methylated in iPSC, iRPE, and xRPE in both patient 1 and patient 2.(B) Genome browser shot of *PTPRT*. From top to bottom, tracks represent CGIs, gene models, and mCG levels of both strands in Fibro1, 2; iPSC1, 2; iRPE1, 2; xRPE1, 2; nRPE1--4; and cRPE1--4. Note that promoter CGI is heavily methylated in iPSC, iRPE, and xRPE from patient 1 but not patient 2.(C) Emergence of PMDs around hypermethylated CGIs. Average methylation profile is shown for the top 50 CGIs contributing to IC5 and IC14 in ICA-based clustering of CGIs ([Figure 2](#fig2){ref-type="fig"}C).(D) Overlap between hypermethylated CGIs and CGIs surrounded by PMDs (Fisher\'s exact test, p = 1.8 × 10^−11^).(E) Methylation heatmap of 50 imprinted DMRs.(F) Methylation heatmap of X-linked gene promoters. Rows include 1,061 TSS-proximal regions in 773 X-linked genes with enough WGBS coverage, of which 493 (47%) regions in 394 genes appear to subject to XCI.(G) Expression levels of candidate XCI genes. Log2 value of the expression ratio between iRPE1 and cRPE4 (\[FPKM +0.01\]~iRPE1~/\[FPKM +0.01\]~cRPE4~) is shown for 45 and 349 genes, which are likely escaping from and subject to XCI in iRPE1, being labeled as XCI (−) and XCI (+), respectively.

Among the signature genes, *PTPRT* was noteworthy because its promoter CGI was hypermethylated in the reprogrammed cells derived from patient 1 but not patient 2 ([Figure 4](#fig4){ref-type="fig"}B). At the *PTPRT* locus, differential methylation occurred not only at the promoter CGI but also in its flanking regions; the regions on both sides of the CGI displayed compromised methylation levels to comprise PMDs in iRPE1, whereas the regions were fully methylated in iRPE2 ([Figure 4](#fig4){ref-type="fig"}B). These findings prompted us to examine whether other CGIs also showed a similar pattern, and we focused on IC14 and IC5 of CGI clustering ([Figure 2](#fig2){ref-type="fig"}C). CGIs that have major contribution to IC14 were hypermethylated upon reprogramming but failed to be properly demethylated during differentiation. By contrast, major contributors to IC5 were hypermethylated upon reprogramming and successfully demethylated during differentiation. We selected the top 50 CGIs that positively contributed to IC14 and IC5, and plotted the methylation levels of these CGIs and their flanking regions. The regions flanking IC5-contributing CGIs were comparably hypermethylated between iRPE and nRPE, whereas the regions flanking IC14-contributing CGIs were significantly hypomethylated in iRPE relative to nRPE ([Figure 4](#fig4){ref-type="fig"}C). Indeed, co-occurrence of the hypermethylation of a CGI and the hypomethylation of the regions flanking the CGI was statistically significant (Fisher\'s exact test, p = 1.0 × 10^−11^; odds ratio = 6.8) ([Figure 4](#fig4){ref-type="fig"}D). We thus suspected a mechanistic linkage between the two methylomic alterations, presumably similar to the one recently demonstrated for extraembryonic lineages and cancers ([@bib24], [@bib34]).

We next examined imprinted genes because reprogramming frequently disrupts genomic imprinting ([@bib18], [@bib11], [@bib3]). We focused on the methylation status of 50 imprinted DMRs (iDMRs) listed in the most comprehensive study conducted on humans thus far ([@bib5]). As expected, almost all iDMRs displayed intermediate methylation levels in the non-reprogrammed cells (fibroblasts, cRPE, and nRPE) ([Figure 4](#fig4){ref-type="fig"}E). However, 6 iDMRs were hypermethylated in the reprogrammed cells (iPSCs, iRPE, and xRPE) derived from both patients, and an additional 13 iDMRs in 3 imprinted loci showed hypermethylation in the reprogrammed cells derived from patient 2. Thus, hypermethylation occurred at 12% and 38% of the iDMRs in iRPE1 and iRPE2, respectively. For instance, *PEG3* was fully methylated at its promoter CGI and was transcriptionally silenced in iRPE ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Conversely, *ZDBF2* was hypermethylated at its upstream iDMR in iRPE, but its expression was higher in iRPE than in cRPE and nRPE ([Figure S4](#mmc1){ref-type="supplementary-material"}A). A similar gain of iDMR methylation associated with an elevated mRNA level of *ZDBF2* was reported for a case of Temple syndrome ([@bib15]).

Finally, we examined the status of X chromosome inactivation (XCI) in patient 1 because XCI is frequently eroded in human pluripotent stem cells and their derivatives ([@bib18], [@bib11], [@bib29], [@bib30]). We used the WGBS data of the non-reprogrammed RPE cells (nRPE and cRPE) to identify 394 candidates for genes subject to XCI (XCI genes), in which the TSS-proximal regions (TSS ± 500 bp) displayed low (≤10%) and intermediate (20%--45%) methylation levels in the male and female cells, respectively ([Figure S4](#mmc1){ref-type="supplementary-material"}B). These XCI genes comprised 51% of X-linked genes (394 of the 773 genes with enough WGBS coverage) and significantly overlapped with previously reported XCI genes ([@bib2], [@bib38]) ([Figure S4](#mmc1){ref-type="supplementary-material"}C), and most TSS-proximal regions of these genes (87%) overlapped with CGIs ([Figure S4](#mmc1){ref-type="supplementary-material"}B). We next compared the methylation levels of the genes between the reprogrammed and non-reprogrammed female cells. Notably, 45 out of 394 gene promoters (11%) showed prominent hypomethylation (≤5%) in iPSC1, iRPE1, and xRPE1, which indicated their escape from XCI ([Figure 4](#fig4){ref-type="fig"}F). For instance, the promoter CGI of *MST4* showed ∼50% methylation level in fibroblasts derived from patient 1 and other female control RPE samples, but was almost fully demethylated in the patient\'s iPSCs, iRPE, and xRPE ([Figure S4](#mmc1){ref-type="supplementary-material"}D). As expected, the 45 genes apparently escaping from XCI were approximately 2-fold derepressed in iRPE1 compared with cRPE4 (Wilcoxon\'s test, p = 3.1 × 10^−9^), whereas the remaining 349 genes displayed largely comparable expression levels between the two samples ([Figure 4](#fig4){ref-type="fig"}G). These results collectively illustrated a significant erosion of XCI and thus an impairment of dosage compensation in iRPE1.

Correlation between Differential Methylation and Gene Expression {#sec2.5}
----------------------------------------------------------------

To investigate the overall effects of differential methylation on gene expression, we examined the correlation between DMRs and differentially expressed genes (DEGs) using iRPE1, nRPE1, and nRPE2, because both WGBS and RNA sequencing (RNA-seq) data were available for these samples. We analyzed the WGBS data using metilene ([@bib14]) under the same criteria as above ([Figures 3](#fig3){ref-type="fig"}A and 3B) to reveal 1,783 hyper-DMRs and 638 hypo-DMRs between iRPE1 and nRPE1/2. We then identified 1,254 and 205 genes proximal to, or within 5 kb from, 1,200 hyper-DMRs and 321 hypo-DMRs, respectively. No proximal genes were identified for 583 hyper-DMRs and 317 hypo-DMRs, whereas 32 genes were proximal to both hyper-DMRs and hypo-DMRs. We also analyzed the RNA-seq data using EdgeR ([@bib31]) to identify DEGs, which revealed 144 and 303 genes upregulated and downregulated in iRPE1 relative to nRPE1/2, respectively; these genes are hereafter referred to as up-DEGs and down-DEGs. Thus, we identified 1,427 (=1,254 + 205 − 32) DMR-proximal genes and 447 (=144 + 303) DEGs in total ([Figure 5](#fig5){ref-type="fig"}A; [Table S5](#mmc2){ref-type="supplementary-material"}). These two sets of genes overlapped markedly: overlap was statistically significant between down-DEGs and genes proximal to hyper-DMRs (Fisher\'s exact test, p = 3.7 × 10^−13^; odds ratio 3.3) and between up-DEGs and genes proximal to hypo-DMRs (Fisher\'s exact test, p = 1.0 × 10^−8^; odds ratio 9.1) ([Figure S5](#mmc1){ref-type="supplementary-material"}A).Figure 5Correlation between DMRs and DEGs(A) Venn diagram for DMR-proximal genes and DEGs. Note that DMRs and DEGs used in this analysis are identified between iRPE1 and nRPE1/2.(B) GO enrichment analysis of DEGs proximal to hyper-DMRs.(C) Correlation between gene-body methylation and expression in four visual-cycle genes.(D) Co-occurrence of CGIs and proximal down-DEGs in hyper-DMRs (Fisher\'s exact test, p = 1.8 × 10^−3^).(E) Ladder charts for methylation levels of hyper-DMRs in iRPE and xRPE. Hyper-DMRs are divided into those bearing and depleted of CGIs. Red lines indicate the mean methylation change.

We next examined whether genes with specific functions were enriched among DMR-proximal DEGs. Intriguingly, 59 down-DEGs proximal to hyper-DMRs exhibited an enrichment of genes related to visual perception ([Figure 5](#fig5){ref-type="fig"}B). One of these genes, *RLBP1*, encodes the cellular retinaldehyde-binding protein, which is critically involved in the visual cycle; this metabolic pathway regenerates 11-*cis*-retinal from all-*trans*-retinal generated upon photon absorption ([@bib17]) and was demonstrated to be functional in iRPE both *in vitro* and *in vivo* ([@bib25]). The finding on *RLBP1* led us to inspect the methylation status of other visual-cycle genes, and we revealed hypermethylation at their gene bodies in iRPE compared with nRPE, as exemplified by *RPE65* ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Among the five visual-cycle genes that function in RPE, four genes (*RBP1*, *RPE65*, *RLBP1*, and *RDH5*) exhibited inverse correlations between the levels of gene-body methylation and mRNA abundance in iRPE1, cRPE2/4, and nRPE1/2 ([Figure 5](#fig5){ref-type="fig"}C). Notably, these genes showed demethylation upon xenotransplantation ([Figure S5](#mmc1){ref-type="supplementary-material"}C). From the inverse correlations and methylation levels in xRPE, we might expect 3.5- to 7.8-fold induction of these genes after xenotransplantation, although unavailability of relevant RNA samples precluded direct examination of this prediction ([Figure S5](#mmc1){ref-type="supplementary-material"}C). The remaining gene, *LRAT*, harbored a hypo-DMR in the upstream flanking region of its promoter CGI, whose methylation level was inversely correlated with the expression level of *LRAT* mRNA ([Figure S5](#mmc1){ref-type="supplementary-material"}D).

The observations on the visual-cycle genes prompted us to examine the origin and fate of DEG-proximal DMRs. The methylation heatmaps suggested that hyper-DMRs proximal to down-DEGs were concentrated to clusters 4 and 5, which were largely depleted of CGIs, amenable to xenotransplantation-induced demethylation, and enriched for proximal genes involved in visual perception ([Figure 3](#fig3){ref-type="fig"}A). Accordingly, we detected significant overlap between hyper-DMRs proximal to down-DEGs and those depleted of CGIs (Fisher\'s exact test, p = 1.8 × 10^−3^) ([Figure 5](#fig5){ref-type="fig"}D). Hyper-DMRs depleted of CGIs appeared to be more prone to xenotransplantation-induced demethylation than hyper-DMRs bearing CGIs ([Figure 5](#fig5){ref-type="fig"}E). These observations on hyper-DMRs suggested a correlation among the presence of proximal down-DEGs, lack of CGIs, and xenotransplantation-induced demethylation. *In vivo* conditions after xenotransplantation might have either mitigated hypermethylation of hyper-DMRs to derepress proximal down-DEGs or derepressed down-DEGs to induce demethylation of proximal hyper-DMRs.

Transplantation-Induced Restoration of Non-CpG Methylation Missing in iRPE {#sec2.6}
--------------------------------------------------------------------------

As well as mCG, we also examined the status of non-CpG methylation (mCH; H = A, C, or T) ([Figures 6](#fig6){ref-type="fig"}A and 6B). As expected from previous studies ([@bib20], [@bib21]), DNA methylation occurred almost exclusively at CG sites in fibroblasts, whereas iPSCs displayed notable levels of mCHs, particularly in the context of CHG ([Figures 6](#fig6){ref-type="fig"}A and 6B). Conversely, nRPE unexpectedly harbored a high level of mCHs in the context of both CHG and CHH ([Figures 6](#fig6){ref-type="fig"}A and 6B). The mCH level of nRPE1 was lower than those of the other nRPE samples for unknown reasons but still higher than that of fibroblasts ([Figure S6](#mmc1){ref-type="supplementary-material"}A). Previously, CAG and CAC were identified as mCH hotspots in pluripotent stem cells and neural cells, respectively ([@bib21], [@bib22], [@bib8], [@bib33]). In our samples, CAG and CAC showed the highest methylation levels in iPSCs and nRPE, respectively ([Figure 6](#fig6){ref-type="fig"}C). In nRPE, the other CAs (i.e., CAA, CAG, and CAT) and CTC displayed the second highest mCH levels after CAC, similarly to those in neural cells ([@bib22]) ([Figures 6](#fig6){ref-type="fig"}C and [S6](#mmc1){ref-type="supplementary-material"}A). Note that mCHs in ESCs and neurons were shown to correlate positively and negatively with gene expression, respectively ([@bib7], [@bib20], [@bib22]). In nRPE, both promoter and gene-body mCH levels were inversely correlated with gene-expression levels ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Among the genes featuring high promoter mCH levels in nRPE, we detected an enrichment of genes involved in development and differentiation of mesodermal tissues ([Figure S6](#mmc1){ref-type="supplementary-material"}C).Figure 6Dynamic Change of Non-CpG Methylation(A) Mean mCHG levels of each cell type (H = A, C, or T).(B) Mean mCHH levels of each cell type.(C) Radar chart for sequence contexts of mCH. Methylation levels are plotted for the 12 possible CHN sequence contexts. The numbers in the left of the CCG axis indicated log2 values of methylation levels (i.e., 1%, 2%, 4%, 8%, and 16%).

Notably, iRPE failed to recapitulate the high mCH level, a unique feature of nRPE ([Figures 6](#fig6){ref-type="fig"}A, 6B, and [S6](#mmc1){ref-type="supplementary-material"}A). We also noted that cRPE lost mCH ([Figures 6](#fig6){ref-type="fig"}A, 6B, and [S6](#mmc1){ref-type="supplementary-material"}A). We thus intended to determine whether *in vitro* cultivation might have caused the lack of mCH in iRPE and whether *in vivo* conditions might increase mCHs. In accordance with this scenario, xRPE exhibited higher mCH levels than iRPE ([Figures 6](#fig6){ref-type="fig"}A, 6B, and [S6](#mmc1){ref-type="supplementary-material"}A). Importantly, mCHs in nRPE and xRPE shared an almost identical preference in terms of their sequence contexts ([Figure 6](#fig6){ref-type="fig"}C). Moreover, the genomic distributions of mCHs appeared largely comparable between nRPE and xRPE, although the mCH levels of xRPE were not as high as those of nRPE ([Figure S6](#mmc1){ref-type="supplementary-material"}D). Thus, *in vivo* conditions can likely remodel the iRPE methylome and thereby cause mCH accumulation in a physiologically relevant manner.

Taken together, these results suggest that mCHs in RPE share characteristics similar to those of mCHs in neural cells and can respond to the cellular environment. Importantly, the responsiveness was faithfully recapitulated in iRPE. Therefore, we expect the iRPE sheet in the patient\'s eye to accumulate mCHs, making its methylome even closer to that of nRPE.

Discussion {#sec3}
==========

The results of base-resolution methylome analyses performed here supported proper differentiation of the iRPE used in the first-in-human trial of iPSC-based autologous transplantation. However, the results also delineated the differences between iRPE and nRPE; emergence of PMDs in iRPE, diverse DMRs between iRPE and nRPE, and the lack of mCHs in iRPE. Because some of these differences were observed even between cRPE and nRPE, they could be attributed to the effects of *in vitro* cultivation and might be mitigated under *in vivo* conditions after transplantation. Indeed, xenotransplantation to mouse remodeled the iRPE methylome to demethylate hyper-DMRs proximal to genes suppressed in iRPE and to accumulate mCHs in a physiologically relevant manner. These results demonstrated the plasticity exhibited by the iRPE methylome in responding appropriately to the *in vivo* environment for further functional maturation. By contrast, PMDs and hypermethylated CGIs were refractory to *in vivo* environment-induced mitigation, at least within the period of observation in this study. It is conceivable that these methylomic alterations are within a clinically acceptable range of epigenetic variations, considering the satisfactory outcome of patient 1. Further investigation is nevertheless required to elucidate the biological and clinical significance of the alterations. It would be also critical to delineate the normal/physiological range of methylomic variations based on WGBS of a much larger number of nRPE for more precise evaluation of iRPE. The iPSC-derived grafts are expected to function properly for an extended period of time in the recipients, during which they would be inevitably exposed to various pathophysiological changes. It is thus ideal that they are comparable with their natural counterparts in their capability of responding to such changes. Since the methylome serves as a good indicator of cellular potential, its sequencing can play an important role in evaluating iPSC-derived grafts. The findings reported here should provide a useful reference for examining the methylomes of various iPSC-derived cells.

Experimental Procedures {#sec4}
=======================

Samples {#sec4.1}
-------

The DNA and RNA samples analyzed in this study were prepared as described previously ([@bib26]). See [Supplemental Information](#mmc1){ref-type="supplementary-material"} for details.

WGBS {#sec4.2}
----

All WGBS libraries were prepared using the PBAT method from ∼100 ng of genomic DNA without using any global PCR amplification ([@bib27], [@bib28]). Illumina sequencing was conducted on HiSeq2500 using 100-nt single-read mode. WGBS reads were mapped to the human reference genome sequence (hg19) using Bmap (<http://itolab.med.kyushu-u.ac.jp/BMap/>). All these experiments and the following analyses were carried out in accordance with our institutional guidelines and were approved by the Ethics Committee for Human Genome and Gene Analysis Research at the Kyushu University Hospital Campus (approval number 626-00). The publicly available WGBS data on human ESC H1 and H9 ([@bib20]) were downloaded from the database and processed similarly for comparison.

RNA-Seq {#sec4.3}
-------

See [Supplemental Information](#mmc1){ref-type="supplementary-material"} for details.

Bioinformatics Analysis {#sec4.4}
-----------------------

### Methylation Levels {#sec4.4.1}

Methylation levels were determined for individual CG and CH sites covered at least once and 10 times, respectively. Methylation levels of sliding windows, promoters, gene bodies, CGIs, and TSS-proximal regions were determined by averaging the methylation levels of CG/CH sites in individual features.

### Methylome Segmentation and PMD Detection {#sec4.4.2}

Methylome segmentation was conducted using SimpleChangepointCalculator ([@bib39]; <http://itolab.med.kyushu-u.ac.jp/CPT/>). Global segmentation patterns were visualized as MDL plots, which displays the size, the methylation level, and the number of domains ([@bib39]). Segmented regions that are larger than 10 kb in size and lower than 70% in mean methylation level were defined as PMDs on the basis of the original definition ([@bib20]).

### Cluster Analysis {#sec4.4.3}

We applied three unsupervised classification methods, namely hierarchical clustering, ICA, and PCA, to mean methylation levels of 100-kb sliding windows, promoters (\<2 kb upstream of TSS), gene bodies, and CGIs. Besides the raw mCG levels, we also used the outputs of ICA and PCA to generate the Euclidian distance matrices for hierarchical clustering by Ward\'s method. In the hierarchical clustering using the outputs of ICA and PCA, the common component was removed. ICA was done using the fastICA package in R, which implements the algorithm of [@bib12]. All heatmaps or clustering were performed using the ComplexHeatmaps library in bioconductor ([@bib6]).

### Identification of DMRs {#sec4.4.4}

DMRs between iRPE and nRPE were identified using metilene with default parameters ([@bib14]). DMRs were filtered to retain those containing at least 20 CpGs with a q value less than 0.01 and methylation difference larger than 30%. To classify DMRs between iRPE and nRPE based on methylation status in the other samples, we conducted k-means clustering using the function k-means of the amap package in R. We determined the cluster numbers so that characteristic clusters were most evidently highlighted.

### Motif Analysis {#sec4.4.5}

Motif enrichment analysis for known transcription factor-binding motifs within the DMRs was performed using the findMotifsGenome.pl of HOMER ([@bib9]) with the "-size given," "-mask," and "-cpg" parameters. The threshold for motif identification was a p value of 1.0 × 10^−7^.

### Functional Enrichment Analysis {#sec4.4.6}

All functional enrichment analysis with gene ontology (GO) biological process terms was performed using the topGO package in R ([@bib1]). To avoid overly general or specific terms, GO terms annotating more than 500 or fewer than 10 genes were removed. A p value of 0.01 was set to be the significance level for gene sets, with an additional requirement of at least 3 genes with annotated biological functions.
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